Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis

被引:2
|
作者
Luo, Tao [1 ]
Chen, Jie [1 ]
Liu, Jun-Jie [2 ]
Li, Hang [2 ]
You, Xue-Mei [1 ]
Wang, Hong-Liang [1 ]
Zhu, Shao-Liang [1 ]
Li, Le-Qun [1 ]
机构
[1] Guangxi Med Univ, Dept Hepatobiliary Surg, Affiliated Tumor Hosp, 71 He Di Rd, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Dept Ultrasound, Affiliated Tumor Hosp, Nanning, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2016年 / 9卷
关键词
cyclin D1 G870A; single nucleotide polymorphism; hepatocellular carcinoma; meta-analysis; GENE POLYMORPHISM; CANCER-RISK; BREAST; SUSCEPTIBILITY; POPULATIONS; ACTIVATION; PROGNOSIS; VARIANT;
D O I
10.2147/OTT.S108754
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Cyclin D1 (CCND1) G870A polymorphism may be associated with hepatocellular carcinoma (HCC) risk, but the results of previous studies were inconsistent. Available evidence was meta-analyzed to assess their potential association. Methods: Databases PubMed, EMBASE, Cochrane Library, Web of Science, Chinese Biomedical Literature database, China National Knowledge Infrastructure, and Google Scholar were systematically searched. Meta-analyses were performed to investigate the association of G870A polymorphism with HCC risk by calculating odds ratios (ORs) and 95% confidence intervals (CIs) from the data of relevant case-control studies. Results: Results of this meta-analysis of six case-control studies involving 1,030 cases and 1,683 controls indicate that G870A polymorphism was not associated with HCC risk in any of the five genetic models tested (recessive model: AA vs GG + AG: OR = 1.38, 95% CI = 0.95-2.00, P = 0.09; dominant model: AG + AA vs GG: OR = 1.38, 95% CI = 0.87-2.20, P = 0.17; homozygous model: AA vs GG: OR = 1.60, 95% CI = 0.87-2.94, P = 0.13; heterozygous model: AG vs GG: OR = 1.24, 95% CI = 0.86-1.79, P = 0.25; allelic model: A vs G: OR = 1.30, 95% CI = 0.95-1.80, P = 0.10). Subgroup analyses according to ethnicity showing marginally significant association between this single nucleotide polymorphism and HCC risk indicate that G870A may be significantly associated with HCC risk in Caucasian populations (recessive model: AA vs GG + AG: OR = 2.34, 95% CI = 1.60-3.42, P<0.0001; dominant model: AG + AA vs GG: OR = 2.44, 95% CI = 1.19-4.97, P = 0.01; homozygous model: AA vs GG: OR = 3.42, 95% CI = 1.80-6.50, P = 0.0002; allelic model: A vs G: OR = 2.06, 95% CI = 1.31-3.24, P = 0.002), but not in Asian populations. Conclusion: Available evidence suggests that no significant association between G870A polymorphism and HCC risk was found in either total populations or Asian populations. However, significant association was found in Caucasian populations. These results should be verified and extended in further detailed and well-designed studies involving larger, multiethnic samples.
引用
收藏
页码:4483 / 4489
页数:7
相关论文
共 50 条
  • [41] Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer
    Ho-Pun-Cheung, Alexandre
    Assenat, Eric
    Thezenas, Simon
    Bibeau, Frederic
    Rouanet, Philippe
    Azria, David
    Cellier, Dominic
    Grenier, Jean
    Ychou, Marc
    Senesse, Pierre
    Lopez-Crapez, Evelyne
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (04): : 1094 - 1101
  • [42] CCND1 G870A Polymorphism with Altered Cyclin D1 Transcripts Expression Is Associated with the Risk of Glioma in a Chinese Population
    Chen, Xiangmei
    Zhao, Tianshu
    Li, Li
    Xu, Chunhui
    Zhang, Xiaolei
    Tse, Vincent
    Zhang, Ting
    Liu, Xiaoqian
    Lu, Fengmin
    DNA AND CELL BIOLOGY, 2012, 31 (06) : 1107 - 1113
  • [43] GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore
    Hong, Y
    Eu, KW
    Seow-Choen, F
    Fook-Chong, S
    Cheah, PY
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (07) : 1037 - 1044
  • [44] Critical appraisal and trial sequential meta-analysis for the association of CCND1 G870A gene polymorphism with the risk for colorectal cancer in Asian population
    Mathkor, Darin M.
    Madkhali, Nora
    Mandal, Raju K.
    Dailah, Hamad G.
    Areeshi, Mohammed Y.
    Haque, Shafiul
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2024, 36 (02): : 34 - 40
  • [45] Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis
    Yu, Jia-Yun
    Hu, Fan
    Du, Wei
    Ma, Xue-Lei
    Yuan, Kun
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2017, 80 (04) : 191 - 203
  • [46] CCND1 G870A polymorphism and cervical cancer risk: a case–control study and meta-analysis
    Jing Ni
    Meilin Wang
    Miaomiao Wang
    Shilong Fu
    Delan Zhou
    Zhengdong Zhang
    Suping Han
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 489 - 494
  • [47] Association between CTLA4?+?49A/G polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis
    Tan, Xiujuan
    Liu, Chunfeng
    Sun, Lingling
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2024, 43 (04) : 302 - 315
  • [48] Cyclin D1 rs9344 G&gt;A polymorphism and gastric cancer risk: a meta-analysis
    Zhang, Sheng
    Wang, Yafeng
    Jiang, Heping
    Liu, Chao
    Sun, Bin
    Tang, Weifeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1594 - 1602
  • [49] CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis
    Lu, Cheng
    Dong, Jing
    Ma, Hongxia
    Jin, Guangfu
    Hu, Zhibin
    Peng, Yuzhu
    Guo, Xirong
    Wang, Xinru
    Shen, Hongbing
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (03) : 571 - 575
  • [50] Genetic polymorphism of CCND1 G870A and esophageal cancer susceptibility: A meta-analysis
    He, Wenwu
    Zeng, Yanbei
    Long, Jianxiong
    Zhou, Qiuxi
    Hu, Yanling
    Chen, Mingwu
    BIOMEDICAL REPORTS, 2013, 1 (02) : 303 - 307